Antigenic changes of L5178Y lymphoma after treatment with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide in vivo. [electronic resource]
- Journal of the National Cancer Institute Jan 1976
- 89-93 p. digital
Publication Type: Journal Article
0027-8874
10.1093/jnci/56.1.89 doi
Animals Antigens, Neoplasm Carmustine--therapeutic use Immunization Immunization, Passive Immunosuppression Therapy Leukemia, Experimental--drug therapy Lymphocytes--immunology Male Mice Radiation Effects Triazenes--pharmacology